Bio-Techne Corp (TECH)
75.63
+2.20
(+3.00%)
USD |
NASDAQ |
May 02, 16:00
75.63
0.00 (0.00%)
After-Hours: 20:00
Bio-Techne Revenue (Quarterly): 272.60M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 272.60M |
| September 30, 2023 | 276.94M |
| June 30, 2023 | 301.32M |
| March 31, 2023 | 294.15M |
| December 31, 2022 | 271.58M |
| September 30, 2022 | 269.66M |
| June 30, 2022 | 288.23M |
| March 31, 2022 | 290.38M |
| December 31, 2021 | 269.28M |
| September 30, 2021 | 257.72M |
| June 30, 2021 | 259.03M |
| March 31, 2021 | 243.55M |
| December 31, 2020 | 224.25M |
| September 30, 2020 | 204.20M |
| June 30, 2020 | 175.83M |
| March 31, 2020 | 194.68M |
| December 31, 2019 | 184.93M |
| September 30, 2019 | 183.24M |
| June 30, 2019 | 191.66M |
| March 31, 2019 | 184.86M |
| December 31, 2018 | 174.51M |
| September 30, 2018 | 162.97M |
| June 30, 2018 | 180.25M |
| March 31, 2018 | 163.97M |
| December 31, 2017 | 154.15M |
| Date | Value |
|---|---|
| September 30, 2017 | 144.61M |
| June 30, 2017 | 156.58M |
| March 31, 2017 | 144.04M |
| December 31, 2016 | 131.81M |
| September 30, 2016 | 130.58M |
| June 30, 2016 | 134.76M |
| March 31, 2016 | 130.97M |
| December 31, 2015 | 120.91M |
| September 30, 2015 | 112.38M |
| June 30, 2015 | 117.66M |
| March 31, 2015 | 114.16M |
| December 31, 2014 | 111.95M |
| September 30, 2014 | 108.48M |
| June 30, 2014 | 92.52M |
| March 31, 2014 | 95.56M |
| December 31, 2013 | 84.02M |
| September 30, 2013 | 85.67M |
| June 30, 2013 | 79.48M |
| March 31, 2013 | 80.99M |
| December 31, 2012 | 75.08M |
| September 30, 2012 | 75.02M |
| June 30, 2012 | 78.68M |
| March 31, 2012 | 83.62M |
| December 31, 2011 | 74.66M |
| September 30, 2011 | 77.60M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
175.83M
Minimum
Jun 2020
301.32M
Maximum
Jun 2023
244.91M
Average
259.03M
Median
Jun 2021
Revenue (Quarterly) Benchmarks
| Agilent Technologies Inc | 1.658B |
| Bio-Rad Laboratories Inc | 681.18M |
| Revvity Inc | 649.92M |
| Twist Bioscience Corp | 71.50M |
| AIM ImmunoTech Inc | 0.065M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 27.46M |
| Total Expenses (Quarterly) | 234.59M |
| EPS Diluted (Quarterly) | 0.17 |
| Enterprise Value | 11.85B |
| Gross Profit Margin (Quarterly) | 64.78% |
| Profit Margin (Quarterly) | 10.08% |
| Earnings Yield | 1.82% |
| Operating Earnings Yield | 2.13% |
| Normalized Earnings Yield | 1.823 |